Japan Intellectual Property Rights: C6'-SUBSTITUTED LOCKED NUCLEIC ACID-MODIFIED CAP ANALOG AND USE THEREOF

Japan, Jan. 23 -- HANGZHOU TIANLONG PHARMACEUTICAL CO LTD has got intellectual property rights for 'C6'-SUBSTITUTED LOCKED NUCLEIC ACID-MODIFIED CAP ANALOG AND USE THEREOF.' Other related details are as follows:

Application Number: JP,2025-002926

Category (FI): A61K47/28,A61K47/24,A61K47/18,A61K9/16,A61K39/00@G,C12N15/11@Z,A61P43/00,105,A61K31/712,A61K31/711,C12P19/34@A,C12N15/88@Z,C12N9/10,C07H21/02,A61K47/34,A61K47/22,A61K47/42,A61K47/36

Stage: Grant (IP right document published.)

Filing Date: Jan. 8, 2025

Publication Date: July 22, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.